Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

  • End date
    Oct 1, 2023
  • participants needed
  • sponsor
    City of Hope Medical Center
Updated on 3 December 2021
Accepts healthy volunteers


This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.



I. To determine the number of high risk women with abnormal screening breast MRI and morphologically normal biopsy over 7 years.


I. To determine if WNT10B/mutant p53 expression as measured in the 0-month biopsy predicts women with an abnormal MRI/non-cancerous biopsy who will progress to cancer over 7 years.


I. To determine the predictive accuracy of WNT10B with MRI, of which will be compared with MRI alone using the C-index.


Participants undergo standard of care high risk breast cancer screening MRIs at baseline and follow-up and blood sample collection at baseline. Participants undergo collection of breast tissue samples at any breast biopsy or breast surgery.

Condition Chronic Diarrhea, Adverse Effects, Drugs, Breast Cancer - HER2 Positive, Primary Immunodeficiency, Brain Function, Metastatic Triple-Negative Breast Cancer, Diet and Nutrition, Peripheral Arterial Occlusive Disease, Skin Wounds, Razor Bumps (Pseudofolliculitis Barbae), Pediatric Health, Near-Sighted Corrective Surgery, Chronic Shoulder Pain, Recurrent Respiratory Papillomatosis, Healthy Subject, Injection Port, Anal Dysplasia, Vaginal Atrophy
Treatment laboratory biomarker analysis, magnetic resonance imaging, biospecimen collection, Biopsy of Breast
Clinical Study IdentifierNCT03303846
SponsorCity of Hope Medical Center
Last Modified on3 December 2021


Yes No Not Sure

Inclusion Criteria

Women who are undergoing screening breast MRI as per standard of care for high-risk breast cancer screening
Willing to donate left-over tissue if patient undergoes a breast biopsy and/or breast surgery
Willing to have about 40 mL of blood (approximately 3 tablespoons) drawn
Documented informed consent of the participant

Exclusion Criteria

Allergy or intolerance to gadolinium
Inability to undergo breast MRI (e.g. claustrophobia)
Participants with active cancer diagnosis (exception: skin cancer, biopsy-proven atypical lobular, ductal hyperplasia and/or lobular carcinoma in situ)
Previous diagnosis of stage 4 cancer
Participants who have received cytotoxic chemotherapy within 1 year prior to screening breast MRI
Participants who have received endocrine therapy within 1 year prior to screening breast MRI
Participants who have received breast radiation within 1 year prior to screening breast MRI
Radiation to both breasts
Pregnant and/or lactating within 1 year prior to screening breast MRI
Receives screening breast MRIs at an outside facility other than the consenting institution
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note